Jump to content

Chloralodol

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 18:01, 28 November 2021 (Alter: chapter-url, pages. URLs might have been anonymized. Add: date. Formatted dashes. | Use this bot. Report bugs. | Suggested by AManWithNoPlan | #UCB_webform 731/2198). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Chloralodol
Clinical data
ATC code
Legal status
Legal status
  • US: Schedule III (No longer marketed in the US)
Identifiers
  • 2-methyl-4-(2,2,2-trichloro-1-hydroxyethoxy)
    pentan-2-ol
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.020.577 Edit this at Wikidata
Chemical and physical data
FormulaC8H15Cl3O3
Molar mass265.56 g·mol−1
3D model (JSmol)
  • ClC(Cl)(Cl)C(O)OC(CC(O)(C)C)C
  • InChI=1S/C8H15Cl3O3/c1-5(4-7(2,3)13)14-6(12)8(9,10)11/h5-6,12-13H,4H2,1-3H3 checkY
  • Key:QVFWZNCVPCJQOP-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Chloralodol (Chlorhexadol) is a hypnotic/sedative.[1] It is a Schedule III drug in the USA; however, it is not currently marketed in the United States so it is no longer prescribed.

References

  1. ^ Sittig M (22 October 2013). "Chloralodol". Pharmaceutical Manufacturing Encyclopedia (3rd ed.). William Andrew Publishing. pp. 945–946. ISBN 978-0-8155-1856-3.